2Settimana
Unfortunately, I made a large partial sale and only have 1 share left. Notwithstanding this, I have reported positively often enough and consider it a blatant buy candidate. They only suffer from the image of the mRNA vaccination and the associated opinion on Corona. Nevertheless, the technology is very good and so is the pipeline. They also have a unique AI department and stable anchor shareholders. So basically it's just the uncertainty, Germany mRNA where the uncertainty wasn't the problem for me now
•
22
•
2Settimana
@topicswithhead Well, if you always knew beforehand 😅
I topped up at €85 in March and May, and at €82 in June. But it could also have been a case of falling into a knife.
And the skepticism about mRNA and vaccinations in general will be of little interest to those affected. Unfortunately, there are enough of them, and every straw is a chance to prolong life. Nothing is as final as death 😥
What many people don't realize is that the pharmaceutical research sector in general was and still is an early driver for AI. BioNTech is also very well positioned in this area.
I topped up at €85 in March and May, and at €82 in June. But it could also have been a case of falling into a knife.
And the skepticism about mRNA and vaccinations in general will be of little interest to those affected. Unfortunately, there are enough of them, and every straw is a chance to prolong life. Nothing is as final as death 😥
What many people don't realize is that the pharmaceutical research sector in general was and still is an early driver for AI. BioNTech is also very well positioned in this area.
•
11
•2Settimana
@TomTurboInvest Don't get me wrong. I didn't sell too early, I sold right at the high. It still annoys me because I would have liked to have a few more shares. I just had to liquidate money for something else. Hence the 1 share to follow
•
11
•2Settimana
@topicswithhead But if you have caught the high well, then you will also be very pleased with a current entry, because you can buy them again at a much lower price.
I also sold mine near the high, but then got back in too early, but thanks to the additional purchases I now have a buy-in of €99 again - the psychological <€100 is good 🤪
I also sold mine near the high, but then got back in too early, but thanks to the additional purchases I now have a buy-in of €99 again - the psychological <€100 is good 🤪
••
2Settimana
@TomTurboInvest I want in, but then my entry price would no longer be 79 but just under 100, so I want to wait for 99.99 as well. At least that still gives me a good feeling
•
11
•2Settimana
@topicswithhead Given the volatility of the last few months, this could happen again, if so - then I'll add more 💰
•
11
•2Settimana
@TomTurboInvest only believe if through the election or an escalation. We are slowly approaching the first drugs and retail investors are also losing their fear of investing. My plan is to have the first successes in 2025/2026.
•
11
•